Abstract | BACKGROUND: THE ROLE OF IMMUNOGLOBULIN THERAPY: However, high dose immunoglobulin therapy is still indicated in a few cases, especially in life-threatening immune peripheral thrombocytopenia, and in recurrent foetal loss: in the latter indication, immunoglobulin therapy alone is efficient in 80% of cases. FUTURE PROSPECTS:
|
Authors | O Blétry, A S Blanc, A M Piette |
Journal | La Revue de medecine interne
(Rev Med Interne)
Vol. 20 Suppl 4
Pg. 410s-413s
( 1999)
ISSN: 0248-8663 [Print] France |
Vernacular Title | Intérêt des immunoglobulines intraveineuses au cours du syndrome des antiphospholipides. |
PMID | 10522314
(Publication Type: English Abstract, Journal Article, Review)
|
Chemical References |
- Anticoagulants
- Fibrinolytic Agents
- Immunoglobulins, Intravenous
- Vitamin K
|
Topics |
- Anticoagulants
(therapeutic use)
- Antiphospholipid Syndrome
(complications, immunology, therapy)
- Fibrinolytic Agents
(therapeutic use)
- Humans
- Immunoglobulins, Intravenous
(therapeutic use)
- Patient Selection
- Prospective Studies
- Retrospective Studies
- Thrombocytopenia
(etiology)
- Thrombosis
(etiology)
- Treatment Outcome
- Vitamin K
(antagonists & inhibitors)
|